pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4457 |
Genomic Coordinates | chr5: 1309310 - 1309377 |
Description | Homo sapiens miR-4457 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4457 | |||||||||||||||||||||
Sequence | 43| UCACAAGGUAUUGACUGGCGUA |64 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | PCMTD2 | ||||||||||||||||||||
Synonyms | C20orf36 | ||||||||||||||||||||
Description | protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2 | ||||||||||||||||||||
Transcript | NM_001104925 | ||||||||||||||||||||
Other Transcripts | NM_018257 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on PCMTD2 | |||||||||||||||||||||
3'UTR of PCMTD2 (miRNA target sites are highlighted) |
>PCMTD2|NM_001104925|3'UTR 1 GTCTCCTGTTTGAAAGGGGGAAATAGGAAGAGCAGATTGCTGAGTGTGAAGTTCGTGCTGCCTGTGTGCTGTTGAAGGGT 81 CACCTGGAGGCAGACGTTGTGGGGAAGGGAACTGCTGGGCTCATCCACACCATGGTTTTCTTCTAGTTCCTGATTGACCT 161 CTAAAATTCTATTCAGTTGTATGATTTGTTTACATAGTTCCACAAGACCTTCATTGCATAGAAGATTGTTTTCCCAAAGT 241 GGAGAGAATCTTCATAGAGAAAAAGAGAAGGCTGTTTCTTTTTCGGCTCTGACGAAACACTGAAGTCTGCGTAAGAGAGA 321 CTGTTTGATGACCGTCCCTCATGCAACATGCACGGTACTCACTAAAAATGAAAACTGAAGTGGAAACTAACCTGTGTTGC 401 TTATAAAGTGTGAAAGCACAAGCTTATAAATGTATAAAATCTTTTCTGGGTGTGACGCACCTGCGTCCAAGTTTGAATTT 481 TTATGATATGTACCACTTAATTACTGGCACTGAGTATCACTGAATTTCTTAGTTTTCTAGTGGGGAAACATTATTGAGAA 561 GCCCTCCCTTATTTTAAGTAAGTTGATTAAATCTTATGTGAGTTGCCAGTTGTAATTTTTCAAAGGAAAAATTTTGATGG 641 GGTGGAGGAATGAATTGCCAGATAATCTTTCTGGAATTCCGAGAGAATTCCAAAGAGGGTTTTTTTTTTTTTTTTTAGGA 721 CATCTTTTGATACCTTTAAAAGAACCACTGTCAAGTAATCCTTAAAAGAATATCTTGGAAAAGGAAACAGATTTTTTCCT 801 GTGTGTAAGCAATAAGTGAAGTTACATTTGCCCTAACCCTAGGGATGATTCTTTACCCAGTTTTAAAGCCCATCATGGTA 881 TTCTAAGGTGTTGACACCCTCCATCCTCAGAGCAGGTCGAAAATATTAAATAGACTGGGGACTCTATGATGGGCAGCCTG 961 TGCTTTTTGACTTCAGTTTGCTATTTTTCTGTGATCACATTAGTACTGATTCATAGATTCTATCTTTTATAATTCTGGAG 1041 AAAAAGATTTGTTAGTTTTGTAATTTTTTTGTAAGACCAAATGTATGTATTTTAGTAGCTCCATTGCATGAGAAGAGTGT 1121 AACTCACACTGACTTGTGATATCAGCCTTCTCTGGGCCTTGTGTGTGGAGAGCTTTCTATCTTACCAAGTGGTAGGGCTA 1201 AAAGAACAACAGCCTTTTTGGTAGTCACATAGCAGAATGATCAGAGTTACATTGCTTATTCCAAAACATTGGTTCTTTTT 1281 AAAACATTTTTTTTTACCCAAAGAAAAGAATAATAGAAATTACTAACAATAAATATAAATTCAGAGTGTTGATATAGGAT 1361 TCAGTATCCAGAGTTTATTTTTAATCTTAATCCTCAGCTTCTTGGGAGTTGCTGGGCTTCAGTGTCTCTGTGGTTTCACC 1441 AGCTTAGCTTGAGCTCTGGTTATTTTGGATCTTTTCTGCTTTTTTTAAGTAACTGAGTCATTTTTACCACACAGTCCAGT 1521 TTGCATGTATAGCTAGGAAACATGTATTGCTCTAGATTGGGCAGTTTAAGTCATTTTAAAGAAAGTTAGTTCATAGTTGT 1601 TGCCTTTTAACTCATAGTCAAGCTTCAGTCTTTCAAAGAGAAATGTGTGATTTTCATTTACTTGCTGATATTTTGTAGTT 1681 TGGAGATCCTTGTGGGCATTATTCTAACTGATACGTAGACACTTACTTGGAAATTTTTGGACATTATATTAAATGAGTGC 1761 TATCTGTGAAATTGGTTATATTAGGTGGCTTGACTAATGTTTTTTCTATAATTGTATATGGACTGCATTTTTAAAAAAAC 1841 CGCATTTGCCTTTATGCTAGATTGTAAAAAATTATATTAGAATGCATAAGACATGTTTTTCCTTCATATGCTAGACTTTT 1921 CCTAGCATTTCGTATTTCTGTGTTGTCAGTGTGTGATTTTTAAACCGGAATTTGGTTTAAAAAAAATCTGGTGGTAATAT 2001 ATGTGAGAAATACTTTGGTGTTTACCTTATGAAAATAAAGGATTGTAAGTAAAGTTTCCTGCGCACCTTATACCAGAATT 2081 CAGTATAATACACTACTTTCTGTTTTCAAACAGATAAATCATAATATAGTCTGTATTATCTGTAAGATCTGTCTTGTAAA 2161 CCACATTCTTGACAACTATTTGCTTTTGAGTAGTTTGTATTTTAATATGTGACTTTTGTCTTGAAAAGTAGTAAAGCCAT 2241 AGACTTGTGCAAAACAAGTTTCAAGTTTATAGATATTAAGTTTGTAATGTGAGCATCAAATGTGTATGTAAAAATACTTT 2321 TTACCAGTCTGGAACTTGGGAAAATCCAGGGAATTTGAAACATAGATTTTAATGAGCTGGTAAACACAAATCATGTCAAT 2401 AAAGGTAGTCAGGATATTTTATCCTTAGCATTGCTTCTGCATCCTGTGTAGGATTCCAATTCTTGAATATGTTCTTTTCA 2481 AAATCTTAAGAAAAGAACCTTTTTTCTTTATTAACATCATGTGTTTACTTTCAGCAAATATTTGTATTACTGCTTGATTC 2561 TGTGACAGTCACAATAGATGTAGAGAAGGCATTATTTTTCATTAATAAATGTGAAATTGGAATGGAAAAAAAAAAAAAAA 2641 AAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 55251.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000308824.6 | 3UTR | AUCCUUGUGGGCAUUAUUCUAAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000308824.6 | 3UTR | UUUGGAGAUCCUUGUGGGCAUUAUUCUAACUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000308824.6 | 3UTR | AUCCUUGUGGGCAUUAUUCUAACUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
83 hsa-miR-4457 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT098032 | SOBP | sine oculis binding protein homolog | 2 | 2 | ||||||||
MIRT202580 | PCMTD2 | protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2 | 2 | 6 | ||||||||
MIRT247137 | WEE1 | WEE1 G2 checkpoint kinase | 2 | 4 | ||||||||
MIRT349266 | PTBP1 | polypyrimidine tract binding protein 1 | 2 | 2 | ||||||||
MIRT363756 | EIF4EBP1 | eukaryotic translation initiation factor 4E binding protein 1 | 2 | 2 | ||||||||
MIRT443586 | FAM84B | family with sequence similarity 84 member B | 2 | 2 | ||||||||
MIRT452333 | EIF5AL1 | eukaryotic translation initiation factor 5A-like 1 | 2 | 2 | ||||||||
MIRT453864 | ZBTB40 | zinc finger and BTB domain containing 40 | 2 | 4 | ||||||||
MIRT471486 | PDE4D | phosphodiesterase 4D | 2 | 4 | ||||||||
MIRT476290 | GMFB | glia maturation factor beta | 2 | 8 | ||||||||
MIRT479897 | CCDC117 | coiled-coil domain containing 117 | 2 | 4 | ||||||||
MIRT484251 | ANK1 | ankyrin 1 | 2 | 2 | ||||||||
MIRT491473 | TMEM214 | transmembrane protein 214 | 2 | 2 | ||||||||
MIRT493804 | GAN | gigaxonin | 2 | 6 | ||||||||
MIRT499252 | VAV3 | vav guanine nucleotide exchange factor 3 | 2 | 4 | ||||||||
MIRT502271 | HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | 2 | 4 | ||||||||
MIRT504651 | RPL9 | ribosomal protein L9 | 2 | 6 | ||||||||
MIRT505211 | UBN2 | ubinuclein 2 | 2 | 8 | ||||||||
MIRT508952 | SNRPB | small nuclear ribonucleoprotein polypeptides B and B1 | 2 | 4 | ||||||||
MIRT512691 | POP1 | POP1 homolog, ribonuclease P/MRP subunit | 2 | 2 | ||||||||
MIRT513320 | SCUBE3 | signal peptide, CUB domain and EGF like domain containing 3 | 2 | 2 | ||||||||
MIRT513870 | HOXA5 | homeobox A5 | 2 | 2 | ||||||||
MIRT517342 | ZNF529 | zinc finger protein 529 | 2 | 4 | ||||||||
MIRT518947 | LSG1 | large 60S subunit nuclear export GTPase 1 | 2 | 2 | ||||||||
MIRT520867 | SUGT1 | SGT1 homolog, MIS12 kinetochore complex assembly cochaperone | 2 | 2 | ||||||||
MIRT528325 | GIGYF2 | GRB10 interacting GYF protein 2 | 2 | 2 | ||||||||
MIRT531990 | SLCO1B3 | solute carrier organic anion transporter family member 1B3 | 2 | 2 | ||||||||
MIRT533298 | USP46 | ubiquitin specific peptidase 46 | 2 | 2 | ||||||||
MIRT545257 | TRIM36 | tripartite motif containing 36 | 2 | 4 | ||||||||
MIRT547038 | POGZ | pogo transposable element derived with ZNF domain | 2 | 2 | ||||||||
MIRT556103 | MOAP1 | modulator of apoptosis 1 | 2 | 2 | ||||||||
MIRT558321 | DR1 | down-regulator of transcription 1 | 2 | 2 | ||||||||
MIRT558521 | CSRNP3 | cysteine and serine rich nuclear protein 3 | 2 | 2 | ||||||||
MIRT560906 | TMED10 | transmembrane p24 trafficking protein 10 | 2 | 2 | ||||||||
MIRT568448 | ARPP19 | cAMP regulated phosphoprotein 19 | 2 | 2 | ||||||||
MIRT570586 | OTUD7B | OTU deubiquitinase 7B | 2 | 2 | ||||||||
MIRT572799 | SIGLEC14 | sialic acid binding Ig like lectin 14 | 2 | 2 | ||||||||
MIRT573863 | C9orf78 | chromosome 9 open reading frame 78 | 2 | 2 | ||||||||
MIRT575058 | P2ry1 | purinergic receptor P2Y, G-protein coupled 1 | 2 | 5 | ||||||||
MIRT609931 | SLC38A1 | solute carrier family 38 member 1 | 2 | 4 | ||||||||
MIRT610836 | ZNF585A | zinc finger protein 585A | 2 | 4 | ||||||||
MIRT611474 | P2RY1 | purinergic receptor P2Y1 | 2 | 7 | ||||||||
MIRT613569 | YY2 | YY2 transcription factor | 2 | 2 | ||||||||
MIRT618626 | GREB1 | growth regulation by estrogen in breast cancer 1 | 2 | 2 | ||||||||
MIRT620606 | SAP30 | Sin3A associated protein 30 | 2 | 2 | ||||||||
MIRT621017 | CLSTN3 | calsyntenin 3 | 2 | 4 | ||||||||
MIRT635314 | FAM179A | TOG array regulator of axonemal microtubules 2 | 2 | 2 | ||||||||
MIRT635919 | GLTSCR2 | NOP53 ribosome biogenesis factor | 2 | 2 | ||||||||
MIRT640598 | TM9SF4 | transmembrane 9 superfamily member 4 | 2 | 2 | ||||||||
MIRT641784 | YWHAB | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta | 2 | 4 | ||||||||
MIRT644067 | IQCE | IQ motif containing E | 2 | 2 | ||||||||
MIRT648288 | TRAPPC2L | trafficking protein particle complex 2 like | 2 | 2 | ||||||||
MIRT658085 | FOXR2 | forkhead box R2 | 2 | 2 | ||||||||
MIRT659077 | DEPTOR | DEP domain containing MTOR interacting protein | 2 | 2 | ||||||||
MIRT665307 | ZBTB37 | zinc finger and BTB domain containing 37 | 2 | 2 | ||||||||
MIRT665975 | SYTL4 | synaptotagmin like 4 | 2 | 2 | ||||||||
MIRT666302 | SLC25A25 | solute carrier family 25 member 25 | 2 | 2 | ||||||||
MIRT674906 | RASSF9 | Ras association domain family member 9 | 2 | 2 | ||||||||
MIRT680086 | THAP1 | THAP domain containing 1 | 2 | 2 | ||||||||
MIRT681488 | DIP2A | disco interacting protein 2 homolog A | 2 | 2 | ||||||||
MIRT691244 | DFNB59 | pejvakin | 2 | 2 | ||||||||
MIRT692362 | AGTRAP | angiotensin II receptor associated protein | 2 | 2 | ||||||||
MIRT693035 | MB21D1 | Mab-21 domain containing 1 | 2 | 2 | ||||||||
MIRT693837 | STAT5A | signal transducer and activator of transcription 5A | 2 | 2 | ||||||||
MIRT694479 | LRTOMT | leucine rich transmembrane and O-methyltransferase domain containing | 2 | 2 | ||||||||
MIRT696070 | ZNF264 | zinc finger protein 264 | 2 | 2 | ||||||||
MIRT696578 | TTC21B | tetratricopeptide repeat domain 21B | 2 | 2 | ||||||||
MIRT696760 | MTFMT | mitochondrial methionyl-tRNA formyltransferase | 2 | 2 | ||||||||
MIRT697307 | ZNF652 | zinc finger protein 652 | 2 | 2 | ||||||||
MIRT700152 | RNF115 | ring finger protein 115 | 2 | 2 | ||||||||
MIRT701056 | PARP2 | poly(ADP-ribose) polymerase 2 | 2 | 2 | ||||||||
MIRT701198 | OTUD3 | OTU deubiquitinase 3 | 2 | 2 | ||||||||
MIRT701335 | NSD1 | nuclear receptor binding SET domain protein 1 | 2 | 2 | ||||||||
MIRT702656 | ITGA3 | integrin subunit alpha 3 | 2 | 2 | ||||||||
MIRT703618 | FBXO45 | F-box protein 45 | 2 | 2 | ||||||||
MIRT704673 | CHTOP | chromatin target of PRMT1 | 2 | 2 | ||||||||
MIRT708894 | ZNF780A | zinc finger protein 780A | 2 | 2 | ||||||||
MIRT711620 | DGKH | diacylglycerol kinase eta | 2 | 2 | ||||||||
MIRT713745 | TMEM81 | transmembrane protein 81 | 2 | 2 | ||||||||
MIRT719712 | CD101 | CD101 molecule | 2 | 2 | ||||||||
MIRT720294 | DLGAP3 | DLG associated protein 3 | 2 | 2 | ||||||||
MIRT722606 | CCDC152 | coiled-coil domain containing 152 | 2 | 2 | ||||||||
MIRT724566 | ACSBG1 | acyl-CoA synthetase bubblegum family member 1 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|